← Back to All Filings

UNH Exec Receives Dividend Equivalents on RSUs

Low SignificanceDecember 18, 2025 at 5:36:50 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UNH Exec Receives Dividend Equivalents on RSUs

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025/12/18 Significance: Low

Insider: Conway Patrick Hugh Title: Chief Executive Officer, Optum | Relationship: Officer

Transaction: • Type: Grant (Dividend Equivalent) • Shares: 67.721 • Price: $0.00 • Value: $0 • Owned After: 10,603.915

Key Insight: This is a routine, non-discretionary acquisition of dividend equivalents on existing restricted stock units, not a new market purchase or grant. It has no market significance.

Market Context: This is a standard, non-discretionary transaction for an executive at a mega-cap company like UnitedHealth ($291.55B market cap).

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer received a negligible number of shares as dividend equivalents on existing restricted stock units (RSUs), a routine and non-discretionary event.
  • Market Impact: Neutral. This transaction has no impact on the market.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHOSPITAL & MEDICAL SERVICE PLANS

Insider Information

FieldValue
NameConway Patrick Hugh
CIK0002067754
Title/PositionChief Executive Officer, Optum
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved67.721
Price Per Share$0.00
Total Value$0
Shares Owned After10,603.915
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.000%
Shares Transacted67.721
% of Shares Outstanding<0.001%
Post-Transaction Ownership10,603.915 shares (0.001% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction is negligible for a company with a market capitalization of approximately $291.55 billion.
  • Ownership Concentration: The insider's total holdings remain an insignificant fraction of the company's total shares outstanding.
  • Dilution Impact: The dilution from these 67 shares is effectively zero.
  • Transaction Significance: The transaction is a non-discretionary acquisition of dividend equivalents on previously granted RSUs, as noted in the filing's footnote. It holds no trading significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a routine, non-discretionary transaction with zero monetary value and a negligible number of shares involved. It does not signal any change in insider sentiment.

Volume & Sentiment

  • Expected Volume Impact: None. This type of transaction does not influence trading volume.
  • Sentiment Indicator: Neutral. The filing provides no new information to influence market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote clarifies that these shares represent dividend equivalents paid on outstanding restricted stock units. They are not a new discretionary award or market purchase.
Topics:#SECFiling#InsiderTrading#UNH#UnitedHealth#Form4#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.